edoc

Items where contributor is "Heberer, Michael"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2014 | 2013 | 2012 | 2011 | 2009 | 2008

2014

Mele, V. and Muraro, M. G. and Calabrese, D. and Pfaff, D. and Amatruda, N. and Amicarella, F. and Kvinlaug, B. and Bocelli-Tyndall, C. and Martin, I. and Resink, T. J. and Heberer, M. and Oertli, D. and Terracciano, L. and Spagnoli, G. C. and Iezzi, G.. (2014) Mesenchymal stromal cells induce epithelial-to-mesenchymal transition in human colorectal cancer cells through the expression of surface-bound TGF-beta. International journal of cancer, Vol. 134, H. 11. S. 2583-2594.

2013

Gianni-Barrera, R. and Trani, M. and Fontanellaz, C. and Heberer, M. and Djonov, V. and Hlushchuk, R. and Banfi, A.. (2013) VEGF over-expression in skeletal muscle induces angiogenesis by intussusception rather than sprouting. Angiogenesis, Vol. 16, H. 1. S. 123-136.

Mujagic, Edin and Gianni-Barrera, Roberto and Trani, Marianna and Patel, Abdulsamie and Gürke, Lorenz and Heberer, Michael and Wolff, Thomas and Banfi, Andrea. (2013) Induction of aberrant vascular growth, but not of normal angiogenesis, by cell-based expression of different doses of human and mouse VEGF is species-dependent. Human gene therapy methods, Vol. 24, no. 1. S. 28-37.

Helmrich, U. and Di Maggio, N. and Guven, S. and Groppa, E. and Melly, L. and Largo, R. D. and Heberer, M. and Martin, I. and Scherberich, A. and Banfi, A.. (2013) Osteogenic graft vascularization and bone resorption by VEGF-expressing human mesenchymal progenitors. Biomaterials, Vol. 34, no. 21. S. 5025-5035.

Droeser, R. A. and Hirt, C. and Viehl, C. T. and Frey, D. M. and Nebiker, C. and Huber, X. and Zlobec, I. and Eppenberger-Castori, S. and Tzankov, A. and Rosso, R. and Zuber, M. and Muraro, M. G. and Amicarella, F. and Cremonesi, E. and Heberer, M. and Iezzi, G. and Lugli, A. and Terracciano, L. and Sconocchia, G. and Oertli, D. and Spagnoli, G. C. and Tornillo, L.. (2013) Clinical impact of programmed cell death ligand 1 expression in colorectal cancer. European journal of cancer, Vol. 49, H. 9. S. 2233-2242.

Droeser, R. A. and Hirt, C. and Eppenberger-Castori, S. and Zlobec, I. and Viehl, C. T. and Frey, D. M. and Nebiker, C. A. and Rosso, R. and Zuber, M. and Amicarella, F. and Iezzi, G. and Sconocchia, G. and Heberer, M. and Lugli, A. and Tornillo, L. and Oertli, D. and Terracciano, L. and Spagnoli, G. C.. (2013) High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor. PLoS one, Vol. 8, H. 5 , e64814.

Le Magnen, C. and Bubendorf, L. and Rentsch, C. A. and Mengus, C. and Gsponer, J. and Zellweger, T. and Rieken, M. and Thalmann, G. N. and Cecchini, M. G. and Germann, M. and Bachmann, A. and Wyler, S. and Heberer, M. and Spagnoli, G. C.. (2013) Characterization and clinical relevance of ALDHbright populations in prostate cancer. Clinical cancer research, Vol. 19, no. 19. S. 5361-5371.

Le Magnen, C. and Bubendorf, L. and Ruiz, C. and Zlobec, I. and Bachmann, A. and Heberer, M. and Spagnoli, G. C. and Wyler, S. and Mengus, C.. (2013) Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells. European journal of cancer, Vol. 49, H. 4. S. 955-963.

2012

Helmrich, U. and Marsano, A. and Melly, L. and Wolff, T. and Christ, L. and Heberer, M. and Scherberich, A. and Martin, I. and Banfi, A.. (2012) Generation of human adult mesenchymal stromal/stem cells expressing defined xenogenic vascular endothelial growth factor levels by optimized transduction and flow cytometry purification. Tissue engineering. Part C, Methods, Vol. 18, H. 4. S. 283-292.

Wolff, Thomas and Mujagic, Edin and Gianni-Barrera, Roberto and Fueglistaler, Philipp and Helmrich, Uta and Misteli, Heidi and Gurke, Lorenz and Heberer, Michael and Banfi, Andrea. (2012) FACS-purified myoblasts producing controlled VEGF levels induce safe and stable angiogenesis in chronic hind limb ischemia. Journal of cellular and molecular medicine, Vol. 16, H. 1. S. 107-117.

Melly, Ludovic F. and Marsano, Anna and Frobert, Aurelien and Boccardo, Stefano and Helmrich, Uta and Heberer, Michael and Eckstein, Friedrich S. and Carrel, Thierry P. and Giraud, Marie-Noëlle and Tevaearai, Hendrik T. and Banfi, Andrea. (2012) Controlled angiogenesis in the heart by cell-based expression of specific vascular endothelial growth factor levels. Human gene therapy methods, Vol. 23, no. 5. S. 346-356.

Di Maggio, Nunzia and Mehrkens, Arne and Papadimitropoulos, Adam and Schaeren, Stefan and Heberer, Michael and Banfi, Andrea and Martin, Ivan. (2012) Fibroblast growth factor-2 maintains a niche-dependent population of self-renewing highly potent non-adherent mesenchymal progenitors through FGFR2c. Stem cells, Vol. 30, H. 7. S. 1455-1464.

Jakob, M. and Saxer, F. and Scotti, C. and Schreiner, S. and Studer, P. and Scherberich, A. and Heberer, M. and Martin, I.. (2012) Perspective on the evolution of cell-based bone tissue engineering strategies. European surgical research, Vol. 49, H. 1. S. 1-7.

Muraro, Manuele Giuseppe and Mele, Valentina and Däster, Silvio and Han, Junyi and Heberer, Michael and Cesare Spagnoli, Giulio and Iezzi, Giandomenica. (2012) CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines. Stem cells translational medicine, Vol. 1, H. 8. S. 592-603.

Droeser, R. and Zlobec, I. and Kilic, E. and Guth, U. and Heberer, M. and Spagnoli, G. and Oertli, D. and Tapia, C.. (2012) Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers. BMC cancer, Vol. 12 , 134.

Raafat, N. and Sadowski-Cron, C. and Mengus, C. and Heberer, M. and Spagnoli, G. C. and Zajac, P.. (2012) Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope. International journal of cancer, Vol. 131, H. 5 , S. E659-E669.

2011

Mengus, C. and Le Magnen, C. and Trella, E. and Yousef, K. and Bubendorf, L. and Provenzano, M. and Bachmann, A. and Heberer, M. and Spagnoli, G. C. and Wyler, S.. (2011) Elevated levels of circulating IL-7 and IL-15 in patients with early stage prostate cancer. Journal of translational medicine, Vol. 9 , 162. S. 162.

2009

Genewein, U. and Jakob, M. and Bingisser, R. and Burla, S. and Heberer, M.. (2009) Organisation der Notfallstation. Der Chirurg : Zeitschrift für alle Gebiete der operativen Medizin, Vol. 80. S. 130-137.

Candrian, C. and Bonacina, E. and Frueh, J. A. and Vonwil, D. and Dickinson, S. and Wirz, D. and Heberer, M. and Jakob, M. and Martin, I. and Barbero, A.. (2009) Intra-individual comparison of human ankle and knee chondrocytes in vitro: relevance for talar cartilage repair. Osteoarthritis and cartilage, Vol. 17. S. 489-496.

2008

Candrian, C. and Vonwil, D. and Barbero, A. and Bonacina, E. and Miot, S. and Farhadi, J. and Wirz, D. and Dickinson, S. and Hollander, A. and Jakob, M. and Li, Z. and Alini, M. and Heberer, M. and Martin, I.. (2008) Engineered cartilage generated by nasal chondrocytes is responsive to physical forces resembling joint loading. Arthritis and rheumatism, Vol. 58, H. 1. S. 197-208.

Wolf, F. and Candrian, C. and Wendt, D. and Farhadi, J. and Heberer, M. and Martin, I. and Barbero, A.. (2008) Cartilage tissue engineering using pre-aggregated human articular chondrocytes. European cells & materials, Vol. 16. S. 92-99.

Schaeren, Stefan and Jaquiery, Claude and Heberer, Michael and Tolnay, Markus and Vercellotti, Tomaso and Martin, Ivan. (2008) Assessment of nerve damage using a novel ultrasonic device for bone cutting. Journal of oral and maxillofacial surgery, Vol. 66, no. 3. S. 593-596.

Scheufler, Oliver and Schaefer, Dirk J. and Jaquiery, Claude and Braccini, Alessandra and Wendt, David J. and Gasser, Juerg A. and Galli, Raffaele and Pierer, Gerhard and Heberer, Michael and Martin, Ivan. (2008) Spatial and temporal patterns of bone formation in ectopically pre-fabricated, autologous cell-based engineered bone flaps in rabbits. Journal of cellular and molecular medicine, Vol. 12, no. 4. S. 1238-1249.

Feder-Mengus, C. and Wyler, S. and Hudolin, T. and Ruszat, R. and Bubendorf, L. and Chiarugi, A. and Pittelli, M. and Weber, W. P. and Bachmann, A. and Gasser, T. C. and Sulser, T. and Heberer, M. and Spagnoli, G. C. and Provenzano, M.. (2008) High expression of indoleamine 2,3-dioxygenase gene in prostate cancer. European journal of cancer, Vol. 44. S. 2266-2675.

Adamina, M. and Weber, W. P. and Rosenthal, R. and Schumacher, R. and Zajac, P. and Guller, U. and Frey, D. M. and Oertli, D. and Zuber, M. and Heberer, M. and Spagnoli, G. C.. (2008) Heterologous prime-boost immunotherapy of melanoma patients with Influenza virosomes, and recombinant Vaccinia virus encoding 5 melanoma epitopes and 3 co-stimulatory molecules : a multi-centre phase I/II open labeled clinical trial. Contemp Clin Trials, Vol. 29. S. 165-181.

Vonwil, D. and Wendt, D. and Stroebel, S. and Wallny, H. J. and Gygax, D. and Heberer, M. and Martin, I.. (2008) Assessment of TGF-b3 bioactivity for potential bioreactor applications. Biochemical engineering journal, Vol. 39. S. 586-589.

Rosenthal, Rachel and Viehl, Carsten T. and Guller, Ulrich and Weber, Walter P. and Adamina, Michel and Spagnoli, Giulio C. and Heberer, Michael and Zuber, Markus. (2008) Active specific immunotherapy phase III trials for malignant melanoma : systematic analysis and critical appraisal. Journal of the American College of Surgeons, Vol. 207, H. 1. S. 95-105.